ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk owner joins the race for Healthium Medtech
Novo Holdings is the latest challenger in a hotly contested bidding process for Healthium, 99.8% owned by Apax Partners. Buyout funds KKR, Hillhouse, EQT, Blackstone and TA Associates among others have already been shortlisted after the initial rounds, ET
Announcement as on 22 March 2024

Why Novo Nordisk Stock Was a Winner Today
One of the healthcare stocks of the moment, Novo Nordisk (NYSE: NVO), had a good Tuesday on the market. Investors pushed its price 3% higher, more than double the percentage rate increase of the S&P 500 index, on the back of a positive move by an analy
Announcement as on 13 March 2024

Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus
Last week, all of the three widely followed indexes closed in the red. The S&P 500, Dow Jones Industrial Average and the Nasdaq Composite declined 0.3%, 0.9% and 1.2%, respectively.
Announcement as on 11 March 2024

Novo Nordisk's (NVO) Wegovy Gets FDA Nod to Reduce Heart Risk
Novo Nordisk NVO announced that the FDA has approved its supplemental new drug application (sNDA) seeking label expansion for Wegovy (semaglutide 2.4 mg) to reduce the risks of major adverse cardiovascular events (MACE), including
Announcement as on 11 March 2024

Early stage trial of Novo Nordisk oral drug finds 13% weight loss in 12 weeks

Announcement as on 07 March 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.94
  • 12Day Average: 47.32
  • 20Day Average: 45.61
  • 50Day Average: 44.82
  • 100Day Average: 42.3
  • 150Day Average: 45.95
  • 200Day Average: 47.77

NVO Indicators & signals

Indicator MACD (12,26,9)

47.61, 46.1, 1.06
Indicator MACD is in positive zone

Indicator ADX (14)

42.42, 29.19, 11.8
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Mon Jul 2026 49.26 48.55 to 50.42 -2.3% 0.77 times
02 Thu Jul 2026 50.42 48.61 to 50.90 3.36% 0.96 times
01 Wed Jul 2026 48.78 47.80 to 49.55 1.79% 0.85 times
30 Tue Jun 2026 47.92 47.87 to 48.80 -0.85% 0.59 times
29 Mon Jun 2026 48.33 47.44 to 48.48 0.67% 0.64 times
26 Fri Jun 2026 48.01 46.70 to 48.50 0.8% 1.5 times
25 Thu Jun 2026 47.63 47.13 to 48.24 0.46% 0.8 times
24 Wed Jun 2026 47.41 46.51 to 47.65 -0.02% 1.01 times
23 Tue Jun 2026 47.42 46.44 to 47.43 3.31% 1.76 times
22 Mon Jun 2026 45.90 43.87 to 46.45 6.27% 1.29 times
18 Thu Jun 2026 43.19 42.52 to 44.17 -0.76% 0.6 times
17 Wed Jun 2026 43.52 43.46 to 45.00 -0.11% 0.98 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top